Skip to main navigation Skip to search Skip to main content

Assessment of a recently developed boron-based HIF inhibitor as a prospective therapy for renal cell carcinoma (RCC)

Project: Research

Project Details

StatusActive
Effective start/end date08/7/24 → 07/31/26

Funding

  • National Cancer Institute: $80,000.00